Showing 865–880 of 1185 results
The Oncomine Myelodysplastic Syndrome (MDS) Panel detects genetic mutations linked to MDS and blood cancers. Accurate, next-generation sequencing. Book your test today.
The Oncomine Myeloproliferative Neoplasm (MPN) Panel is a cutting-edge genetic test that analyzes key mutations in JAK2, CALR, and MPL, the genes most commonly linked to myeloproliferative disorders. Using advanced next-generation sequencing (NGS), this test provides a highly accurate and efficient way to diagnose and classify MPNs, even when only small or degraded samples are available (as little as 10 ng of DNA or RNA).
The Oncotype DX Breast Cancer (ML) Test is a genomic assay that analyzes the activity of 21 genes in a breast cancer tumor to predict the risk of recurrence and the potential benefit of chemotherapy. Designed for early-stage, hormone receptor-positive, HER2-negative breast cancer patients, it provides a Recurrence Score® result that helps guide personalized treatment decisions. Key benefits include reducing unnecessary chemotherapy, improving patient outcomes, and offering evidence-based insights backed by extensive clinical validation.
Sample Type : Buccal Swab
Methodology : PCR
TAT : 14 Days
An Open MRI Scan (Without Contrast) is a non-invasive imaging procedure that uses magnetic fields and radio waves to create detailed internal body images without the need for contrast dye. Its key features include an open design, making it ideal for claustrophobic or anxious patients, and high-resolution imaging for accurate diagnosis.
The Open MRI Scan With Contrast is an advanced diagnostic imaging procedure designed for enhanced patient comfort and precise results. Unlike traditional closed MRI machines, the open design reduces anxiety and claustrophobia, making it ideal for children, elderly patients, and those with mobility issues.
Get the Organic Acid Quantification by GC/MS in Dubai to detect metabolic imbalances, mitochondrial dysfunction & nutrient deficiencies. Results in 21 days. Book now!
Sample Type : Early Morning Urine
Methodology : Gas Phase Chromatography / Mass Spectrometry (GC-MS)
TAT : 21 Days
Sample Type : Early Morning Urine
Methodology : HPLC – High Performance Liquid Chromatography
TAT : 21 Days
Sample Type : Whole Blood
Methodology : Real-time PCR
TAT : 15 Days
Sample Type : Slides and Block(s)
Methodology : Microscopy
TAT : 21 Days
The Müllerian Hormone (AMH) Ab, Inhibin B, and FSH Test is that comprehensive look. It’s a diagnostic triad that doesn’t just tell you if you are ovulating today; it tells you about your ovarian reserve, your hormonal balance, and your potential fertility for the future.
Sample Type : Serum
Methodology : NA
TAT : 14 Days
Sample Type : 24 Hour Urine
Methodology : Spectrophotometry
TAT : 37 Days